The Effect of Betahistine on Body Weight in Obese Subjects

Summary

The purpose of this study is to examine the effect that betahistine has on body weight in obese subjects.

Conditions

• Obesity

Interventions

DRUG

Betahistine

BEHAVIORAL

Dietary counseling

Sponsors & Collaborators

• OBEcure Ltd.

  lead INDUSTRY

Principal Investigators

• Andrew Ahmann, MD · Covance CRU, Inc

• Louis Aronne, MD · Comprehensive Weight Control Program

• Harold Bays, MD · L-Marc Research Center

• Norman Fishman, MD · Diabetes & Endocrinology Specialists

• Ken Fujioka, MD · Scripps Clinic, Nutrition Metabolic Research

• Jeffrey Geohas, MD · Radiant Research, Inc

• Frank Greenway, MD · Pennington Biodmedical Research Center

• Dean Kereiakes, MD · Lindner Clinical Trial Center

• Diane Krieger, MD · Miami Research Associates, Nutrition Division

• Robert Kushner, MD · NCCR

• Thomas Moretto, MD · American Health Network

• Monica Pierson, MD · Radiant Research

• Sherwyn Schwartz, MD · Diabetes & Glandular Disease Research Associates

• Diane Smith, MD · CSRA Partners in Health

• Philip Toth, MD · Midwest Institute for Clinical Research

• Mervyn Weerasinghe, MD · Rochester Clinical Research

• Richard Weinstein, MD · Diablo Clinical Research

• Lisa Wright, MD · Cahaba Research, Inc

• James Zavoral, MD · Radiant Research, Inc.

• Nir Barak, MD · OBEcure Ltd.

• Yaffa Beck, PhD · OBEcure Ltd.

• Ami Eyal, MD · OBEcure Ltd.

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2007-01-31

Completion

2007-06-30

Countries

• United States

Study Locations